High cost of dalteparin not worth added benefits in cancer Clinical study 30 January 2013 Pages: 4 - 4
Drotrecogin alfa “cost effective option” in severe sepsis in the UK Clinical study 30 January 2013 Pages: 5 - 5
Early initiation of lipid-lowering therapy improves use in ACS Clinical study 30 January 2013 Pages: 5 - 5
Syncope-related hospitalisation costs “alarming” in the US Clinical study 30 January 2013 Pages: 5 - 5
Combo therapy in PD good value whatever way you look at it Clinical study 30 January 2013 Pages: 6 - 6
Patients with migraine willing to fork out for drug that works well Clinical study 30 January 2013 Pages: 6 - 6
Patients, caregivers more willing to pay for quick fix in schizophrenia Clinical study 30 January 2013 Pages: 7 - 7
Progressive resistance training sized up in AIDS-related wasting Clinical study 30 January 2013 Pages: 7 - 7
Alternative medicine use in older US adults exceeds use in general population Media release 30 January 2013 Pages: 8 - 8
Biopsy-and-treat strategy best for HCV infection in US prisons Clinical study 30 January 2013 Pages: 8 - 8
Use of prescribed drugs for chronic diseases suboptimal in SA Clinical study 30 January 2013 Pages: 8 - 8
Atorvastatin top of the class for hypercholesterolaemia in Spain Clinical study 30 January 2013 Pages: 9 - 9
Recombinant EPO a no-go for avoiding transfusion-related adverse events Clinical study 30 January 2013 Pages: 9 - 9
New partnership to fight MTCT of HIV in developing countries Media release 30 January 2013 Pages: 10 - 10
Wyeth joins programme to enhance patient access to medicines Media release 30 January 2013 Pages: 10 - 10